Parkinson’s Disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Over 750 industry clinical trials have been initiated for...
Learn how QMENTA simplifies central vein detection in Multiple Sclerosis. Our solution automates protocol adherence, sequence recognition, and white...
Advance Parkinson’s research with QMENTA's Imaging Hub: cutting-edge imaging, biomarker insights, and cloud-based tools for early detection and...
Discover how the Central Vein Sign (CVS) may enhance diagnostic accuracy, advance research outcomes, and influence the McDonald criteria.
Discover how AI enhances medical imaging workflows, boosting accuracy and efficiency. Learn benefits, challenges, and how QMENTA simplifies AI...
Take a look ahead at our predicted trends for neuroscience in 2025 - where technology, neuroplasticity, and neuroethics are reshaping the way we...
Discover insights into structural and functional aspects of the human brain, potential biomarkers, and applications in psychiatric research.
Companies and technicians that are developing new algorithms to help researches and professionals to diagnose and measure diseases progression...